[New treatments for spinal cord injuries].
Salamanca
Fabio
F
Unidad de Investigación Médica en Genética Humana, Centro Médico Nacional Siglo XXI IMSS, Apartado Postal 12-951 México, D.F. 03020.
D000818:Animals; D019765:Chondroitin ABC Lyase / Q000378:metabolism / Q000494:pharmacology; D011508:Chondroitin Sulfate Proteoglycans / Q000187:drug effects / Q000378:metabolism; D004594:Electrophysiology; D006131:Growth Inhibitors / Q000494:pharmacology; D009185:Myelin Proteins / Q000494:pharmacology; D009416:Nerve Regeneration / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D000070798:Nogo Proteins; D010264:Paraplegia / Q000628:therapy; D011782:Quadriplegia / Q000628:therapy; D051381:Rats; D013119:Spinal Cord Injuries / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*
D011508:Chondroitin Sulfate Proteoglycans; D006131:Growth Inhibitors; D009185:Myelin Proteins; D000070798:Nogo Proteins; C000603197:Rtn4 protein, rat; D019765:Chondroitin ABC Lyase